ALERT CONTENT PLACEHOLDER

About the Phase III Trial

The Advance II Study is sponsored by Functional Neuromodulation Ltd. Phase 1 and 2 of the trial has been completed, and we are in the process of recruiting patients for our Phase III study. If you are interested in applying for this study, please review the information below and contact Martha Lenis, Study Coordinator, for information at 416 603 5800 ext. 2797 or email martha.lenis@uhnresearch.ca.

Eligibility

Ages Eligible for Study: At least 65 years old
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No

Criteria

You will be considered a candidate for this study if you:

  1. Are at least 65 years old.
  2. Have Probable Alzheimer's disease according to the National Institute of Aging Alzheimer's Disease Association criteria.
  3. Must meet certain criteria on cognitive and behavioural rating scales.
  4. Are taking or have previously tried a stable dose of Alzheimer's medication for at least two months.
  5. Have an available caregiver or family member who can accompany you to doctors' visits and reliably report on daily activities and function.